BRAF and malignant colon neoplasm: As colon tumors with MSI-H and BRAF-V600E mutations were also known to have low Wnt signaling27, we analyzed expression levels of Axin2, a prototypical Wnt signaling target, and ZNRF3, relative to RNF43 and BRAF mutation status in the colon cancer cohort.